Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
2011

Impact of Prevnar vaccination on pneumococcal carriage in children

Sample size: 592 publication Evidence: moderate

Author Information

Author(s): Scotet Julie, Baumann Francine, Dupont-Rouzeyrol Myrielle, Grangeon Catherine, Oftadeh Shahin, Garin Benoit, Chanteau Suzanne, Le Hello Simon

Primary Institution: Institut Pasteur de Nouvelle-Calédonie

Hypothesis

The study assesses the impact of the PCV7 vaccine on the nasopharyngeal carriage of Streptococcus pneumoniae in children.

Conclusion

The PCV7 vaccine decreased pneumococcal carriage but led to an increase in non-vaccine strains that are resistant to penicillin.

Supporting Evidence

  • The overall pneumococcal carriage decreased from 52.3% to 42.1%.
  • Vaccine type carriage decreased from 46.9% to 22.2%.
  • Non-vaccine type pneumococci carriage increased from 20.8% to 29.0%.
  • The increase in PRSP carriage was significant in the Northern Province.
  • The increase in PRSP was notably attributed to the vaccine type 19F.

Takeaway

The vaccine helped reduce some bad germs in kids, but it also allowed other germs that are harder to treat to grow more.

Methodology

The study enrolled children aged 2 to 24 months and compared data from before and after the vaccine's introduction.

Limitations

The study may not account for all factors influencing pneumococcal carriage.

Participant Demographics

Healthy children aged 2 to 24 months in New Caledonia.

Statistical Information

P-Value

p < 10-3

Statistical Significance

p < 0.05

Digital Object Identifier (DOI)

10.1186/1753-6561-5-S1-P13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication